The risk for HBV infection in international travelers is generally low, except for certain travelers to regions where the prevalence of chronic HBV infection is high or intermediate (i.e., Hepatitis B surface antigen prevalence of ≥2%).
Hepatitis B vaccination should be administered to unvaccinated persons traveling to those countries.
